Horizon Europe: Obertes les convocatòries del clúster 1 “Health” per l’any 2027

Enviat per Butlletí Recerca el

European CommissionLes convocatòries per l’any 2027 del clúster 1 de Salut del programa Horitzó Europa s’han publicat, i són les últimes oportunitats per abordar les mancances restants, les necessitats de recerca emergents i els reptes futurs identificats en el segon pla estratègic d'Horitzó Europa (2025-2027). 

En línia amb les Directrius Polítiques de la Comissió per al període 2024-2029, que se centren en enfortir la resiliència de l'atenció mèdica, aprofitar la biotecnologia i la intel·ligència artificial, i abordar les necessitats de salut pública, inclòs el suport al desenvolupament de medicaments crítics i enfortir la preparació i la resposta de la societat. Això contribuirà a la prosperitat i la competitivitat sostenibles d'Europa. La col·laboració en recerca i innovació és clau per assolir aquests objectius.

Més concretament, el clúster 1 té com a objectiu contribuir als següents objectius específics (destinations):

  • Destination 1 – Staying healthy in a rapidly changing society.
  • Destination 2 – Living and working in a health-promoting environment.
  • Destination 3 – Tackling diseases and reducing disease burden.
  • Destination 4 – Ensuring equal access to innovative, sustainable and high-quality health care.
  • Destination 5 – Developing and using of new tools, technologies and digital solutions for a healthy society.
  • Destination 6 – Maintaining an innovative, sustainable and competitive EU health industry.

Les següents convocatòries estan obertes fins el 17 de febrer de 2027 a les 17.00 CET:

Staying healthy in a rapidly changing society

  • HORIZON-HLTH-2027-01-STAYHLTH-01: Addressing disabilities through the life course to support independent living and inclusion

Living and working in a health-promoting environment

  • HORIZON-HLTH-2027-01-ENVHLTH-02: Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change
  • HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03: Tools and technologies to support health adaptation to climate change

Tackling diseases and reducing disease burden

  • HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
  • HORIZON-HLTH-2027-01-DISEASE-06: Development of monoclonal antibodies to prevent and treat infections from Flaviviruses
  • HORIZON-HLTH-2027-01-DISEASE-07: Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses
  • HORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobials
  • HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)

Ensuring equal access to innovative, sustainable, and high-quality healthcare

  • HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications

Maintaining an innovative, sustainable, and competitive EU health industry

  • HORIZON-HLTH-2027-01-IND-01: Development of cell-free protein synthesis platforms for discovery and/or production of biologicals

Les següents convocatòries estan obertes fins el 16 de setembre de 2027 a les 17.00 CET:

Developing and using new tools, technologies and digital solutions for a healthy society

  • HORIZON-HLTH-2027-03-TOOL-02: Advancing bio-printing of living cells for regenerative medicine
  • HORIZON-HLTH-2027-03-TOOL-04: Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
  • HORIZON-HLTH-2027-03-TOOL-08: Towards Artificial General Intelligence (AGI) for healthcare

Les següents convocatòries tenen dues fases (two-stage) i la primera fase romandrà oberta fins el 17 de febrer de 2027 a les 17.00 CET: 

Tackling diseses and reducing disease burden

  • HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
  • HORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative diseases

Developing and using new tools, technologies and digital solutions for a healthy society

  • HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases

Maintaining an innovative, sustainable and competitive EU health industry

  • HORIZON-HLTH-2027-02-IND-02-two-stage: Portable and versatile Point-of-care diagnostics

La Comissió Europea organitza una jornada informativa sobre el Clúster 1 en línia el 26 de novembre de 2026. 

Per a qualsevol consulta podeu contactar amb la Ruth Babington, de l’Oficina de Recerca i Innovació (rbabington@rectorat.url.edu). 

+info: Work Programme, Funding and Tenders Opportunities Portal , InfoDay